CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)


Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL


Become EABM
Become Reviewer

Alzheimers Disease, Ceramide, Visfatin and NAD

Volume:7   Issue: 6
Pp: 492-498
James D. Adams Jr.
DOI: 10.2174/187152708787122969

Alzheimers Disease Drug Development: Old Problems Require New Priorities

Volume:7   Issue: 6
Pp: 499-511
Robert E. Becker and Nigel H. Greig
DOI: 10.2174/187152708787122950

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

Volume:7   Issue: 6
Pp: 512-523
L. W. Chen, K. K.L. Yung, Y. S. Chan, D. K.Y. Shum and J. P. Bolam
DOI: 10.2174/187152708787122923

Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach

Volume:7   Issue: 6
Pp: 524-535
M. de Tommaso, M. Sardaro, E. Vecchio, C. Serpino, M. Stasi and M. Ranieri
DOI: 10.2174/187152708787122932

NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis open access plus

Volume:7   Issue: 6
Pp: 536-557
J. Yan and J. M. Greer
DOI: 10.2174/187152708787122941